Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phospholipid scramblase 2 pseudogene (ENSG00000241358) is a genomic DNA sequence highly similar to the protein-coding Phospholipid scramblase 2 (PLSCR2) gene, but it is classified as a pseudogene and does not produce a functional protein. Pseudogenes such as this are not therapeutically actionable and lack biological activity, although they may occasionally play minor regulatory roles at the RNA level. The functional gene, PLSCR2, participates in calcium-dependent phospholipid movement and may be involved in apoptosis, interferon signaling, and immune responses, but the pseudogene itself is not implicated in these pathways[1][3][5]. ENSG00000241358 is not a therapeutic target due to being a pseudogene; its use in research or clinical settings is limited to genomic or evolutionary studies, not therapeutic targeting[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phospholipid scramblase 2 pseudogene.